Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Outperform on Seagen, Raises Price Target to $162

SVB Leerink Maintains Outperform on Seagen, Raises Price Target to $162

SVB Leerink analyst Andrew Berens maintains Seagen (NASDAQ:SGEN) with a Outperform and raises the price target from $160 to $162.

January 20, 2023

1 minute read

SVB Leerink analyst Andrew Berens maintains Seagen (NASDAQ:SGEN) with a Outperform and raises the price target from $160 to $162.

Advanced Health Intelligence Signed Collaboration Agreement with Bin Farhood International Business Management Group

September 11, 7:22 PM

Advanced Health Intelligence Ltd (NASDAQ:AHI) (“AHI” or the “Company”) is pleased to inform shareholders that the Company

January 2, 9:44 AM

Weak home sales data hits China's ailing real estate sector, while PMI data suggests a weakening Chinese manufacturing industry.

April 18, 1:01 PM

Within the last quarter, Anixa Biosciences (NASDAQ:ANIX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

July 29, 9:20 AM

Mizuho analyst Vikram Malhotra maintains Medical Properties Trust (NYSE:MPW) with a Buy and lowers the price target from $26 to $20.